Prediction of Concomitant Nosocomial Infection in Patients Previously Colonized Colorectally by Multidrug-Resistant Bacteria in an SDD Setting

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2024 Aug 29

PMID 39200017

Authors

Sergio Ruiz-Santana

Jose Dearriba-Reyes

Pedro Saavedra

Laura Iglesias-Llorente

Laura Alonso-Acero

Carmen-Rosa Hernandez-Socorro

Catalina Sanchez-Ramirez

Affiliations

Soon will be listed here.

Abstract

Background: Antibiotic resistance is a worldwide concern. This study retrospectively analyzed patients admitted to the ICU of a tertiary hospital over a period of 7 months who were rectally colonized by multidrug-resistant microorganisms. The incidence of concomitant nosocomial infections was estimated, thus providing the risk of a colonizing microorganism producing a nosocomial infection.

Methods: Infections with the same microorganism (concomitant) or different microorganisms (non-concomitant) were analyzed in order to adjust the empirical antibiotic treatment. Patients with rectal colonization by at least one multidrug-resistant bacterium (MDRB) on admission or after ICU admission were included. All patients had complete selective digestive decontamination (SDD) prophylaxis. For univariate analysis, categorical variables are expressed as frequencies and percentages and continuous variables as means and standard deviations, or as medians and interquartile ranges. For multivariate analysis, the model is summarized with -values and hazard ratios with 95% confidence intervals. Survival analysis was conducted using the Kaplan-Meier method, which was performed to evaluate the time elapsed from colonization to infection by the same bacteria. Statistical significance was considered at < 0.05.

Results: Of the 130 patients with MDRB bacterial colonization analyzed, 98 remained free of infection, while 22 developed non-concomitant infections and 10 had infections concomitant to rectal colonizing bacteria. OXA-48-producing bacteria and MDR- spp. incidences were 18.9% (95% CI: 7.96-35.2) and 44.4% (CI: 13.7-78.8), respectively.

Conclusions: OXA-48-producing bacteria and MDR- spp. were the only bacteria associated with the development of infections concomitant to rectal colonization in an SDD setting. The incidence of MDRB infections was low.

References

Oteo J, Bou G, Chaves F, Oliver A . Microbiological methods for surveillance of carrier status of multiresistant bacteria. Enferm Infecc Microbiol Clin. 2016; 35(10):667-675. DOI: 10.1016/j.eimc.2015.12.013. View

Muntean D, Horhat F, Baditoiu L, Dumitrascu V, Bagiu I, Horhat D . Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit. Medicina (Kaunas). 2018; 54(6). PMC: 6307078. DOI: 10.3390/medicina54060092. View

Charlson M, Carrozzino D, Guidi J, Patierno C . Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother Psychosom. 2022; 91(1):8-35. DOI: 10.1159/000521288. View

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

Myburgh J, Seppelt I, Goodman F, Billot L, Correa M, Davis J . Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2022; 328(19):1911-1921. PMC: 9607966. DOI: 10.1001/jama.2022.17927. View

Barbier F, Lipman J, Bonten M . In 2035, will all bacteria be multidrug-resistant? No. Intensive Care Med. 2016; 42(12):2017-2020. DOI: 10.1007/s00134-016-4348-x. View

Daneman N, Sarwar S, Fowler R, Cuthbertson B . Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis. 2013; 13(4):328-41. DOI: 10.1016/S1473-3099(12)70322-5. View

Barrett M . The legacy of penicillin's first patient. Pharmacol Res. 2023; 192:106772. DOI: 10.1016/j.phrs.2023.106772. View

Papafotiou C, Roussos S, Sypsa V, Bampali S, Spyridopoulou K, Karapanou A . Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area. J Antimicrob Chemother. 2022; 77(12):3331-3339. DOI: 10.1093/jac/dkac321. View

10.

De Bus L, Arvaniti K, Sjovall F . Empirical antimicrobials in the intensive care unit. Intensive Care Med. 2024; 50(8):1338-1341. DOI: 10.1007/s00134-024-07453-0. View

11.

Singh V, Chibale K . Strategies to Combat Multi-Drug Resistance in Tuberculosis. Acc Chem Res. 2021; 54(10):2361-2376. PMC: 8154215. DOI: 10.1021/acs.accounts.0c00878. View

12.

Ceccarelli G, Alessandri F, Moretti S, Borsetti A, Maggiorella M, Fabris S . Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma. Pathogens. 2022; 11(11). PMC: 9695038. DOI: 10.3390/pathogens11111295. View

13.

Falcone M, Tiseo G, Galfo V, Giordano C, Leonildi A, Marciano E . Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study). Clin Microbiol Infect. 2021; 28(2):298.e1-298.e7. DOI: 10.1016/j.cmi.2021.06.031. View

14.

Ruiz-Santana S, Mora-Quintero M, Saavedra P, Montiel-Gonzalez R, Sanchez-Ramirez C, Perez-Acosta G . COVID-19 Secondary Infections in ICU Patients and Prevention Control Measures: A Preliminary Prospective Multicenter Study. Antibiotics (Basel). 2022; 11(8). PMC: 9405068. DOI: 10.3390/antibiotics11081016. View

15.

Minozzi S, Pifferi S, Brazzi L, Pecoraro V, Montrucchio G, DAmico R . Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation. Cochrane Database Syst Rev. 2021; 1:CD000022. PMC: 8094382. DOI: 10.1002/14651858.CD000022.pub4. View

16.

Kollef M, Shorr A, Bassetti M, Timsit J, Micek S, Michelson A . Timing of antibiotic therapy in the ICU. Crit Care. 2021; 25(1):360. PMC: 8518273. DOI: 10.1186/s13054-021-03787-z. View

17.

Fernandez-Verdugo A, Fernandez J, Escudero D, Cofino L, Forcelledo L, Telenti M . [Epidemiological surveillance for multidrug-resistant microorganisms in a general ICU]. Rev Esp Quimioter. 2017; 30(3):201-206. View

18.

Lazaro-Perona F, Rodriguez-Tejedor M, Ruiz-Carrascoso G, Diaz-Pollan B, Loeches B, Ramos-Ramos J . Intestinal loads of OXA-48-producing Klebsiella pneumoniae in colonized patients determined from surveillance rectal swabs. Clin Microbiol Infect. 2020; 27(8):1169.e7-1169.e12. DOI: 10.1016/j.cmi.2020.09.054. View

19.

Cohen R, Babushkin F, Cohen S, Afraimov M, Shapiro M, Uda M . A prospective survey of colonization and infection in the intensive care unit. Antimicrob Resist Infect Control. 2017; 6:7. PMC: 5225573. DOI: 10.1186/s13756-016-0167-7. View

20.

McConville T, Sullivan S, Gomez-Simmonds A, Whittier S, Uhlemann A . Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One. 2017; 12(10):e0186195. PMC: 5638409. DOI: 10.1371/journal.pone.0186195. View